Loading...
Market
Will CVS Health's Q4 2024 adjusted EPS meet or exceed $1.70?
3
Resolution / Starting Odds
Yes • 50%
No • 50%
CVS Health's official Q4 2024 earnings report
Story
CVS Replaces CEO Karen Lynch with David Joyner, Lowers Earnings Forecast, Withdraws 2024 Guidance
Oct 18, 2024, 11:38 AM
CVS Health has appointed David Joyner as its new President and Chief Executive Officer, succeeding Karen Lynch, who stepped down after an agreement with the board. The leadership change comes as the company struggles to drive higher profits and stock performance. CVS issued a profit warning, expecting preliminary third-quarter adjusted earnings per share (EPS) between $1.05 and $1.10, significantly below analysts' estimates of $1.70. The company also reported a higher medical loss ratio of 95%, exceeding expectations of 91%, and withdrew its most recent 2024 guidance issued in August. In response, CVS shares tumbled over 13% in pre-market trading.
View original story
Similar markets
Below $1.00 • 25%
$1.00 to $1.10 • 25%
$1.11 to $1.20 • 25%
Above $1.20 • 25%
Less than $90 billion • 25%
$90 billion to $95 billion • 25%
$95 billion to $100 billion • 25%
More than $100 billion • 25%
Increase by more than 10% • 25%
Increase by 0-10% • 25%
Decrease by 0-10% • 25%
Decrease by more than 10% • 25%
Revenue increases • 25%
Revenue decreases • 25%
Net income increases • 25%
Net income decreases • 25%
